Fluvastatin Interferes with Hepatitis C Virus Replication via Microtubule Bundling and a Doublecortin-like Kinase-Mediated Mechanism
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fluvastatin Interferes with Hepatitis C Virus Replication via Microtubule Bundling and a Doublecortin-like Kinase-Mediated Mechanism
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 11, Pages e80304
Publisher
Public Library of Science (PLoS)
Online
2013-11-20
DOI
10.1371/journal.pone.0080304
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus
- (2013) Ludmila Prokunina-Olsson et al. NATURE GENETICS
- miR-122 regulates hepatic lipid metabolism and tumor suppression
- (2012) Jessica Wen et al. JOURNAL OF CLINICAL INVESTIGATION
- Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver
- (2012) Shu-hao Hsu et al. JOURNAL OF CLINICAL INVESTIGATION
- MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis
- (2012) Wei-Chih Tsai et al. JOURNAL OF CLINICAL INVESTIGATION
- Combination of fluvastatin with pegylated interferon/ribavirin therapy reduces viral relapse in chronic hepatitis C infected with HCV genotype 1b
- (2012) Masanori Atsukawa et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Dclk1 distinguishes between tumor and normal stem cells in the intestine
- (2012) Yuki Nakanishi et al. NATURE GENETICS
- Targeting tumor cell metabolism with statins
- (2012) J W Clendening et al. ONCOGENE
- Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex
- (2012) T. Shimakami et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Productive Hepatitis C Virus Infection of Stem Cell-Derived Hepatocytes Reveals a Critical Transition to Viral Permissiveness during Differentiation
- (2012) Xianfang Wu et al. PLoS Pathogens
- DCAMKL-1 Regulates Epithelial-Mesenchymal Transition in Human Pancreatic Cells through a miR-200a-Dependent Mechanism
- (2011) S. M. Sureban et al. CANCER RESEARCH
- Effects of hypolipidemic agent nordihydroguaiaretic acid on lipid droplets and hepatitis C virus
- (2011) Gulam H. Syed et al. HEPATOLOGY
- Hepatitis C Virus-Induced Cancer Stem Cell-Like Signatures in Cell Culture and Murine Tumor Xenografts
- (2011) N. Ali et al. JOURNAL OF VIROLOGY
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Explaining statin inhibition effectiveness of HMG-CoA reductase by quantum biochemistry computations
- (2011) Roner F. da Costa et al. PHYSICAL CHEMISTRY CHEMICAL PHYSICS
- New HCV therapies on the horizon
- (2010) J. Vermehren et al. CLINICAL MICROBIOLOGY AND INFECTION
- Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy
- (2010) Stephen A. Harrison et al. HEPATOLOGY
- Inhibition of Cell Migration and Cell Division Correlates with Distinct Effects of Microtubule Inhibiting Drugs
- (2010) Hailing Yang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hepatitis A and Hepatitis C Viruses: Divergent Infection Outcomes Marked by Similarities in Induction and Evasion of Interferon Responses
- (2010) Lin Qu et al. SEMINARS IN LIVER DISEASE
- Assembly of infectious hepatitis C virus particles
- (2010) Ralf Bartenschlager et al. TRENDS IN MICROBIOLOGY
- Statin Therapy and Serum Transaminases Among a Cohort of HCV-Infected Veterans
- (2009) Louise M. Henderson et al. DIGESTIVE DISEASES AND SCIENCES
- Statins potentiate thein vitroanti-hepatitis C virus activity of selective hepatitis C virus inhibitors and delay or prevent resistance development
- (2009) Leen Delang et al. HEPATOLOGY
- An Open Pilot Study Exploring the Efficacy of Fluvastatin, Pegylated Interferon and Ribavirin in Patients with Hepatitis C Virus Genotype 1b in High Viral Loads
- (2009) Hitomi Sezaki et al. INTERVIROLOGY
- Does fluvastatin favour HCV replicationin vivo? A pilot study on HIV-HCV coinfected patients
- (2009) L. Milazzo et al. JOURNAL OF VIRAL HEPATITIS
- Hepatitis C virus hijacks host lipid metabolism
- (2009) Gulam H. Syed et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Fluvastatin Inhibits Hepatitis C Replication in Humans
- (2008) Ted Bader et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- A Dynamic View of Hepatitis C Virus Replication Complexes
- (2008) B. Wolk et al. JOURNAL OF VIROLOGY
- Association of Hepatitis C Virus Replication Complexes with Microtubules and Actin Filaments Is Dependent on the Interaction of NS3 and NS5A
- (2008) C.-K. Lai et al. JOURNAL OF VIROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now